全文获取类型
收费全文 | 184893篇 |
免费 | 1587篇 |
国内免费 | 102篇 |
专业分类
耳鼻咽喉 | 1221篇 |
儿科学 | 6827篇 |
妇产科学 | 3291篇 |
基础医学 | 17734篇 |
口腔科学 | 1966篇 |
临床医学 | 13099篇 |
内科学 | 33185篇 |
皮肤病学 | 784篇 |
神经病学 | 17219篇 |
特种医学 | 9290篇 |
外科学 | 30405篇 |
综合类 | 2338篇 |
预防医学 | 18471篇 |
眼科学 | 2833篇 |
药学 | 10022篇 |
中国医学 | 654篇 |
肿瘤学 | 17243篇 |
出版年
2023年 | 79篇 |
2022年 | 223篇 |
2021年 | 384篇 |
2020年 | 223篇 |
2019年 | 333篇 |
2018年 | 22230篇 |
2017年 | 17588篇 |
2016年 | 19757篇 |
2015年 | 1261篇 |
2014年 | 1347篇 |
2013年 | 1353篇 |
2012年 | 7802篇 |
2011年 | 21821篇 |
2010年 | 19236篇 |
2009年 | 11928篇 |
2008年 | 20117篇 |
2007年 | 22330篇 |
2006年 | 1087篇 |
2005年 | 2713篇 |
2004年 | 3916篇 |
2003年 | 4754篇 |
2002年 | 2815篇 |
2001年 | 317篇 |
2000年 | 442篇 |
1999年 | 216篇 |
1998年 | 262篇 |
1997年 | 264篇 |
1996年 | 139篇 |
1995年 | 145篇 |
1994年 | 148篇 |
1993年 | 104篇 |
1992年 | 61篇 |
1991年 | 117篇 |
1990年 | 147篇 |
1989年 | 98篇 |
1988年 | 73篇 |
1987年 | 52篇 |
1986年 | 38篇 |
1985年 | 38篇 |
1984年 | 31篇 |
1983年 | 29篇 |
1982年 | 32篇 |
1980年 | 44篇 |
1974年 | 24篇 |
1938年 | 60篇 |
1937年 | 25篇 |
1935年 | 22篇 |
1934年 | 30篇 |
1932年 | 56篇 |
1930年 | 46篇 |
排序方式: 共有10000条查询结果,搜索用时 19 毫秒
21.
22.
Gastroesophageal reflux is the most common benign disorder of the esophagus and laparoscopic Nissen fundoplication has become the standard surgical treatment for its treatment. In our area, where the use of bougie calibration is debatable, postoperative dysphagia is encountered often after this surgery although it is usually not permanent. The aim of this study was to investigate the effect of using a soft silicone tube 39 F in diameter for esophageal calibration during laparoscopic Nissen fundoplication on the incidence of postoperative dysphagia. We divided cases scheduled to undergo laparoscopic Nissen fundoplication between January 2009 and November 2010 into two groups, each consisting 25 patients. Esophageal calibration with a 39 F silicone orogastric tube was used for the first group while there was no operative calibration in the second group. The surgical duration was recorded; the presence and severity of the postoperative dysphagia was calculated by using a dysphagia severity scoring system during the 1-year postoperative follow-up. The dysphagia severity scores were significantly lower in group 1 than group 2 on the postoperative second day and at the end of the first week and first month. We did not find a significant difference at the end of the 6-month and first year. There was also no significant difference regarding surgery duration. The use of a soft orogastric tube 39 F in diameter for esophagus calibration during laparoscopic Nissen fundoplication has significantly decreased the incidence of postoperative transient dysphagia without affecting the duration of surgery. Although dysphagia gradually resolves in the majority of patients, a safe and easy calibration method for its prevention is worth developing, and we believe that the use of our method in larger series could be beneficial. 相似文献
23.
Auda A. Eltahla Fabio Luciani Peter A. White Andrew R. Lloyd Rowena A. Bull 《Viruses》2015,7(10):5206-5224
The hepatitis C virus (HCV) is a pandemic human pathogen posing a substantial health and economic burden in both developing and developed countries. Controlling the spread of HCV through behavioural prevention strategies has met with limited success and vaccine development remains slow. The development of antiviral therapeutic agents has also been challenging, primarily due to the lack of efficient cell culture and animal models for all HCV genotypes, as well as the large genetic diversity between HCV strains. On the other hand, the use of interferon-α-based treatments in combination with the guanosine analogue, ribavirin, achieved limited success, and widespread use of these therapies has been hampered by prevalent side effects. For more than a decade, the HCV RNA-dependent RNA polymerase (RdRp) has been targeted for antiviral development. Direct acting antivirals (DAA) have been identified which bind to one of at least six RdRp inhibitor-binding sites, and are now becoming a mainstay of highly effective and well tolerated antiviral treatment for HCV infection. Here we review the different classes of RdRp inhibitors and their mode of action against HCV. Furthermore, the mechanism of antiviral resistance to each class is described, including naturally occurring resistance-associated variants (RAVs) in different viral strains and genotypes. Finally, we review the impact of these RAVs on treatment outcomes with the newly developed regimens. 相似文献
24.
25.
26.
27.
28.
29.
30.